OBJECTIVES: To present a multi-delay pseudo-continuous ASL (pCASL) protocol that offers simultaneous measurements of cerebral blood flow (CBF) and arterial transit time (ATT), and to study correlations between multi-delay pCASL and CT perfusion in moyamoya disease. METHODS: A 4 post-labeling delay (PLD) pCASL protocol was applied on 17 patients with moyamoya disease who also underwent CT perfusion imaging. ATT was estimated using the multi-delay protocol and included in the calculation of CBF. ASL and CT perfusion images were rated for lesion severity/conspicuity. Pearson correlation coefficients were calculated across voxels between the two modalities in grey and white matter of each subject respectively and between normalized mean values of ASL and CT perfusion measures in major vascular territories. RESULTS: Significant associations between ASL and CT perfusion were detected using subjective ratings, voxel-wise analysis in grey and white matter and region of interest (ROI)-based analysis of normalized mean perfusion. The correlation between ASL CBF and CT perfusion was improved using the multi-delay pCASL protocol compared to CBF acquired at a single PLD of 2 s (P < 0.05). CONCLUSIONS: There is a correlation between perfusion data from ASL and CT perfusion imaging in patients with moyamoya disease. Multi-delay ASL can improve CBF quantification, which could be a prognostic imaging biomarker in patients with moyamoya disease. KEY POINTS: • Simultaneous measurements of CBF and ATT can be achieved using multi-delay pCASL. • Multi-delay ASL was compared with CT perfusion in patients with moyamoya disease. • Statistical analyses showed significant associations between multi-delay ASL and CT perfusion. • Multi-delay ASL can improve CBF quantification in moyamoya disease.
OBJECTIVES: To present a multi-delay pseudo-continuous ASL (pCASL) protocol that offers simultaneous measurements of cerebral blood flow (CBF) and arterial transit time (ATT), and to study correlations between multi-delay pCASL and CT perfusion in moyamoya disease. METHODS: A 4 post-labeling delay (PLD) pCASL protocol was applied on 17 patients with moyamoya disease who also underwent CT perfusion imaging. ATT was estimated using the multi-delay protocol and included in the calculation of CBF. ASL and CT perfusion images were rated for lesion severity/conspicuity. Pearson correlation coefficients were calculated across voxels between the two modalities in grey and white matter of each subject respectively and between normalized mean values of ASL and CT perfusion measures in major vascular territories. RESULTS: Significant associations between ASL and CT perfusion were detected using subjective ratings, voxel-wise analysis in grey and white matter and region of interest (ROI)-based analysis of normalized mean perfusion. The correlation between ASL CBF and CT perfusion was improved using the multi-delay pCASL protocol compared to CBF acquired at a single PLD of 2 s (P < 0.05). CONCLUSIONS: There is a correlation between perfusion data from ASL and CT perfusion imaging in patients with moyamoya disease. Multi-delay ASL can improve CBF quantification, which could be a prognostic imaging biomarker in patients with moyamoya disease. KEY POINTS: • Simultaneous measurements of CBF and ATT can be achieved using multi-delay pCASL. • Multi-delay ASL was compared with CT perfusion in patients with moyamoya disease. • Statistical analyses showed significant associations between multi-delay ASL and CT perfusion. • Multi-delay ASL can improve CBF quantification in moyamoya disease.
Authors: Max Wintermark; Musa Sesay; Emmanuel Barbier; Katalin Borbély; William P Dillon; James D Eastwood; Thomas C Glenn; Cécile B Grandin; Salvador Pedraza; Jean-François Soustiel; Tadashi Nariai; Greg Zaharchuk; Jean-Marie Caillé; Vincent Dousset; Howard Yonas Journal: Stroke Date: 2005-08-11 Impact factor: 7.914
Authors: María A Fernández-Seara; Brian L Edlow; Angela Hoang; Jiongjiong Wang; David A Feinberg; John A Detre Journal: Magn Reson Med Date: 2008-06 Impact factor: 4.668
Authors: Juan Chen; Daniel J Licht; Sabrina E Smith; Shannon C Agner; Stefanie Mason; Sumei Wang; David W Silvestre; John A Detre; Robert A Zimmerman; Rebecca N Ichord; Jiongjiong Wang Journal: J Magn Reson Imaging Date: 2009-02 Impact factor: 4.813
Authors: B J MacIntosh; A C Lindsay; I Kylintireas; W Kuker; M Günther; M D Robson; J Kennedy; R P Choudhury; P Jezzard Journal: AJNR Am J Neuroradiol Date: 2010-01-28 Impact factor: 3.825
Authors: Danny J J Wang; Jeffry R Alger; Joe X Qiao; Matthias Gunther; Whitney B Pope; Jeffrey L Saver; Noriko Salamon; David S Liebeskind Journal: Neuroimage Clin Date: 2013-07-06 Impact factor: 4.881
Authors: Steve Z Martin; Vince I Madai; Federico C von Samson-Himmelstjerna; Matthias A Mutke; Miriam Bauer; Cornelius X Herzig; Stefan Hetzer; Matthias Günther; Jan Sobesky Journal: J Cereb Blood Flow Metab Date: 2014-11-19 Impact factor: 6.200
Authors: Pan Su; Deng Mao; Peiying Liu; Yang Li; Marco C Pinho; Babu G Welch; Hanzhang Lu Journal: Magn Reson Med Date: 2016-12-26 Impact factor: 4.668
Authors: Xueling Suo; Du Lei; Lan Cheng; Nannan Li; Panli Zuo; Danny J J Wang; Xiaoqi Huang; Su Lui; Graham J Kemp; Rong Peng; Qiyong Gong Journal: Hum Brain Mapp Date: 2018-12-07 Impact factor: 5.038
Authors: S Hara; Y Tanaka; Y Ueda; S Hayashi; M Inaji; K Ishiwata; K Ishii; T Maehara; T Nariai Journal: AJNR Am J Neuroradiol Date: 2017-02-16 Impact factor: 3.825
Authors: Audrey P Fan; Jia Guo; Mohammad M Khalighi; Praveen K Gulaka; Bin Shen; Jun Hyung Park; Harsh Gandhi; Dawn Holley; Omar Rutledge; Prachi Singh; Tom Haywood; Gary K Steinberg; Frederick T Chin; Greg Zaharchuk Journal: Stroke Date: 2017-08-01 Impact factor: 7.914